File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Conference Paper: KEYNOTE-495/KeyImPaCT: Phase II biomarker-directed precision oncology study of pembrolizumab-based combination therapy for non–small cell lung cancer

TitleKEYNOTE-495/KeyImPaCT: Phase II biomarker-directed precision oncology study of pembrolizumab-based combination therapy for non–small cell lung cancer
Authors
Gutierrez, MHellmann, MDGubens, MDAggarwal, CATan, DSWFelip, EChiu, WYJLee, JSYang, JCHGaron, EBBasso, ADMa, HFong, LSnyder, AYuan, JHerbst, RS
Issue Date2019
PublisherAmerican Association for Cancer Research. The Journal's web site is located at http://cancerres.aacrjournals.org/
Citation
Proceedings of the 110th American Association for Cancer Research (AACR) Annual Meeting, Atlanta, Georgia, USA. 29 March - 3 April 2019. In Cancer Research, 2019, v. 79 n. 13, Suppl., Abstract CT227 How to Cite?
DOI: http://dx.doi.org/10.1158/1538-7445.AM2019-CT227
Persistent Identifierhttp://hdl.handle.net/10722/279532
ISSN
0008-5472
2021 Impact Factor: 13.312
2020 SCImago Journal Rankings: 4.103
ISI Accession Number ID
WOS:000488129900203

 

DC FieldValueLanguage
dc.contributor.authorGutierrez, M-
dc.contributor.authorHellmann, MD-
dc.contributor.authorGubens, MD-
dc.contributor.authorAggarwal, CA-
dc.contributor.authorTan, DSW-
dc.contributor.authorFelip, E-
dc.contributor.authorChiu, WYJ-
dc.contributor.authorLee, JS-
dc.contributor.authorYang, JCH-
dc.contributor.authorGaron, EB-
dc.contributor.authorBasso, AD-
dc.contributor.authorMa, H-
dc.contributor.authorFong, L-
dc.contributor.authorSnyder, A-
dc.contributor.authorYuan, J-
dc.contributor.authorHerbst, RS-
dc.date.accessioned2019-11-01T07:19:09Z-
dc.date.available2019-11-01T07:19:09Z-
dc.date.issued2019-
dc.identifier.citationProceedings of the 110th American Association for Cancer Research (AACR) Annual Meeting, Atlanta, Georgia, USA. 29 March - 3 April 2019. In Cancer Research, 2019, v. 79 n. 13, Suppl., Abstract CT227-
dc.identifier.issn0008-5472-
dc.identifier.urihttp://hdl.handle.net/10722/279532-
dc.languageeng-
dc.publisherAmerican Association for Cancer Research. The Journal's web site is located at http://cancerres.aacrjournals.org/-
dc.relation.ispartofCancer Research-
dc.relation.ispartofProceedings of the 110th American Association for Cancer Research (AACR) Annual Meeting-
dc.titleKEYNOTE-495/KeyImPaCT: Phase II biomarker-directed precision oncology study of pembrolizumab-based combination therapy for non–small cell lung cancer-
dc.typeConference_Paper-
dc.identifier.emailChiu, WYJ: jwychiu@hku.hk-
dc.identifier.authorityChiu, WYJ=rp01917-
dc.identifier.doi10.1158/1538-7445.AM2019-CT227-
dc.identifier.hkuros308519-
dc.identifier.volume79-
dc.identifier.issue13, Suppl.-
dc.identifier.spageAbstract CT227-
dc.identifier.epageAbstract CT227-
dc.identifier.isiWOS:000488129900203-
dc.publisher.placeUnited States-
dc.identifier.issnl0008-5472-

Export via OAI-PMH Interface in XML Formats

OR

Export to Other Non-XML Formats